Hypofractionated radiation for thymoma and thymic carcinoma
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a shorter course of radiation (hypofractionated radiotherapy) for people with thymoma or thymic carcinoma. It aims to see if fewer, larger doses of radiation are safe and effective for treating these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 74 years old
- You have been diagnosed with a type of thymoma or thymic carcinoma
- Your tumor is at an early to moderate stage (Masaoka-Koga stage I to III)
- You are in generally good health (ECOG score 0-2)
- You have not had chest radiation before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (fewer, larger doses) given after surgery for thymic tumors. The goal is to reduce the chance of the tumor returning while keeping side effects manageable.
This trial tests a shorter course of radiation therapy (hypofractionated) after surgery for people with Stage II or III thymoma or thymic cancer. The goal is to prevent the tumor from coming back.
This trial looks at adding radiation after a complete surgery to remove a thymoma (a tumor from the thymus) at stages II or III. It may help lower the chance the cancer comes back by treating leftover microscopic disease after surgery.
This trial studies proton radiotherapy (a type of radiation) for cancers of the thymus, like thymoma or thymic carcinoma. It may help improve tumor control while limiting radiation exposure to nearby organs.
This study tests a shorter course of radiation therapy (called hypofractionated radiotherapy) for people with head and neck cancer who have already had surgery to remove the tumor. It is for patients with certain 'intermediate-risk' features, aiming to improve outcomes while possibly reducing treatment time.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
Hear when a new Thymoma and Thymic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.